Christopher Duma, MD
Neurological Surgery · Newport Beach, CANPI 1306870845
Payments from drug & device makers
Across 228 payments — averaging $623.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Longeviti Neuro Solutions Inc$126K
- Medtronic$8K
- Osteomed LLC$3K
- Boston Scientific$763
- Insightec,inc$642
- NX Development Corp.$639
- plus $4K from 24 others
What the payments were for
- Consulting fees$13,3009%
- Speaking & faculty fees$113,74980%
- Food & beverage$15,04011%
- Education$1430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Longeviti Neuro Solutions Inc | 16 | $126,111 |
| Medtronic(2 entities) | 103 | $7,629 |
| Osteomed LLC | 3 | $2,784 |
| Boston Scientific | 16 | $763 |
| Insightec,inc | 11 | $642 |
| NX Development Corp. | 2 | $639 |
| Abbott | 16 | $632 |
| Visionrt, Inc. | 1 | $523 |
| Surgical Theater. Inc. | 2 | $317 |
| UCB, Inc. | 11 | $312 |
| Lilly USA, LLC | 7 | $270 |
| Aesculap, Inc. | 4 | $214 |
| Zap Surgical Systems, Inc. | 1 | $201 |
| Monteris Medical Corporation | 1 | $185 |
| AbbVie(2 entities) | 8 | $160 |
| Stryker | 4 | $98 |
| GT Medical Technologies, Inc | 2 | $97 |
| Merck | 4 | $87 |
| Novocure Inc. | 1 | $84 |
| Irras USA, Inc. | 1 | $78 |
| Arbor Pharmaceuticals, Inc. | 4 | $77 |
| Integra Lifesciences Corporation | 2 | $75 |
| Cerapedics Inc. | 1 | $51 |
| Elekta, Inc. | 1 | $45 |
| Terumo BCT, Inc. | 1 | $44 |
| Johnson & Johnson | 1 | $37 |
| Biogen | 1 | $28 |
| Analogic Corporation | 1 | $25 |
| Lemaitre Vascular, Inc. | 1 | $15 |
| Kls-martin L.p. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CLEARFIT$119,887
- INVISISHUNT$11,173
- NEURO-Neur$2,643
- ACTIVA PC$1,682
- STEALTHSTATION S8 PLATFORM$1,006
- AQUAMANTYS$706
- ACTIVA$644
- Gleolan$639
- MAZOR X SYSTEM$444
- Exablate$280
- GENERAL DBS$256
- PlasmaBlade$253
- O-ARM-ST$227
- ZAP-X MV IMAGER$201
- ZAP-X TREATMENT PLANNING SOFTWARE$201
- ZAP-X TREATMENT DELIVERY SOFTWARE$201
- ZAP-X RADIOSURGERY SYSTEM$201
- InvisiShunt Implant Kit$194
- Neuroblate$185
- STEALTH AUTOGUIDE SYSTEM$170
How this compares
$142,231 in reported general payments places this provider in the 85th percentile of 773 neurological surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Newport Beach
- Robert LouisNewport Beach$933K
- Geoffrey ManleySan Francisco$24.9M
- Christopher AmesSan Francisco$7.1M
- Jamshid SalehRedding$4.1M
- Bruce McCormackSan Francisco$3.9M
- Andrew SchreiberSanta Ana$3.9M
- Larry KhooLos Angeles$3M
- Jennie TaylorSan Francisco$2.7M
- Joseph CiacciSan Diego$2.6M
- Nicholas ButowskiSan Francisco$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.